A controlled trial of psychological treatment for the irritable bowel syndrome

Guthrie, Elspeth; Creed, Francis; Dawson, David J.; Tomenson, Barbara

doi:10.1016/0016-5085(91)90215-7

Cited by 431 publications

(197 citation statements)

References 23 publications

Supporting

Mentioning

184

Contrasting

Unclassified

Order By: Relevance

“…25,26 Hiperalgesia visceral, estresse, abuso físico e sexual têm sido elementos associados como participantes do conjunto de dados clínicos, englobado no universo dessa moléstia [1][2][3][4][5][6][7][8][9] , da mesma forma ocorrendo com as enterites bacterianas e virais, sem que, no entanto, seja possível destacar um elemento marcador. 27,28 São tantas as teorias e complexas as investigações e conclusões que a SCI passa a ser vista sob um conjunto heterogêneo de desordens com sintomas parecidos, mas de diferentes etiologias [29][30][31][32] que retroalimentam mais especulações sobre uma causa básica, o que, sem dúvida alguma, favorece a " medicalização" e a emergência de procedimentos subsidiados pela medicina alternativa 33 .…”

Section: Discussionunclassified

Um marcador anatômico e a proposta de tratamento cirúrgico na síndrome do cólon irritável

Santos¹,

Cavalca²,

Quiroz³

2006

Rev bras. colo-proctol.

View full text Add to dashboard Cite

RESUMO: Objetivo: A Síndrome do cólon irritável (SCI) é um distúrbio funcional caracterizado por dor abdominal e mudança de hábito intestinal. .Observando que a Síndrome do ceco móvel (SCM) englobaA síndrome do cólon irritável (SCI) é um distúrbio funcional caracterizado por dor abdominal e mudanças no hábito intestinal, não associadas com qualquer anomalia vista em provas clínicas rotineiras. 1,2 Há duas formas principais da SCI, na dependência do sintoma predominante: SCI com dor abdominal baixa e dispepsia não-ulcerosa em que os pacientes podem ter constipação (SCIC) ou diarréia (SICID), ou pode apresentar constipação e diarréia flutuantes (SICICD). Há, no entanto, um novo subtipo sob investigação denominado de síndrome do cólon pós-infecciosa (SCIPI).

show abstract

Section: Discussionunclassified

Um marcador anatômico e a proposta de tratamento cirúrgico na síndrome do cólon irritável

Santos¹,

Cavalca²,

Quiroz³

2006

Rev bras. colo-proctol.

View full text Add to dashboard Cite

show abstract

“…Other therapeutic advances in the ®eld of IBS are also likely to be far more expensive than current optionsÐthis is already manifest in the case of hypnotherapy 27 and psychotherapy. 29 Against this background, further research into the economics of IBS would be valuable. Such data would provide an indication of the magnitude of the burden in relation to other diseases and thereby supply useful information which could, for example, help determine research prioritization.…”

Section: Discussionmentioning

confidence: 99%

“…In the latter context, a survey of 96 IBS patients in the UK found that 16% had consulted practitioners of alternative medicine about their condition. 26 Evidence has been reported of the effectiveness of hypnotherapy, 27 relaxation exercises 28 and psychological treatment, 29 among other approaches, in alleviating the symptoms of IBS. These techniques, which are not cheap to provide, are probably going to be used more in the future if no new medications are forthcoming.…”

mentioning

confidence: 99%

Clinical economics review: irritable bowel syndrome

Wells

Hahn

Whorwell³

1997

Aliment Pharmacol Ther

View full text Add to dashboard Cite

The ubiquitous nature of irritable bowel syndrome (IBS), coupled with a lack of good treatment options, has created the impression that the condition must represent a large drain on health‐care resources. The literature certainly appears to support this view but is largely based on patients seen in referral centres (10–15%) and it may not be appropriate to extrapolate these data to the IBS population as a whole (85–90%).In addition to reviewing such literature that exists on the economics of IBS, this paper contains some new data, which suggest that the direct costs of the condition, certainly in the UK, may not be quite as high as has previously been assumed. This may be partly due to factors such as the low cost of the drugs used to treat the condition and the tendency for many patients to stop consulting because of disenchantment with the inadequacies of current therapy. Conversely, the indirect and intangible costs of the disorder appear to be much greater, but these burdens obviously do not have such an impact on those responsible for purchasing and providing health care for IBS sufferers.Paradoxically, if a new, effective therapy for IBS were forthcoming, the situation could change dramatically, especially if it involved a new drug. Any such agent would inevitably be more expensive than anything available today, leading to a potentially dramatic escalation in the direct costs of this disorder.

show abstract

“…40,41 Hospital-based studies have reported that IBS may benefit from individual and group cognitive behavioural therapy (CBT). [42][43][44][45][46] …”

Section: Antispasmodics and Cognitive Behavioural Therapymentioning

confidence: 99%

“…69 Harvey and colleagues also reported that greater initial psychological disturbance was associated with poorer outcome in hypnotherapy 70 but, in contrast, Guthrie and colleagues showed that patients with features of anxiety or depression, who identified stress as a factor that exacerbated their abdominal pain and who had IBS of recent onset were most likely to benefit from psychotherapy. 42 They found major differences in physical and psychological status between chronic attendees and new referrals and reported that chronic attendees perceived their abdominal and non-colonic symptoms as being more severe and were more concerned about the possible serious effects of their IBS. Lembo and colleagues showed that patients with IBS of more than 5 years duration had greater psychological morbidity than those with IBS of less than 2 years' duration.…”

Section: Predictors Of Outcomementioning

confidence: 99%

Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial

Kennedy¹,

Chalder²,

McCrone³

et al. 2006

Health Technol Assess

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. Contact Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email.Paying by official purchase order You can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK.We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NHS R&D HTA ProgrammeT he research findings from the NHS R&D Health Technology Assessment (HTA) Programme directly influence key decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC) who rely on HTA outputs to help raise standards of care. HTA findings also help to improve the quality of the service in the NHS indirectly in that they form a key component of the 'National Knowledge Service' that is being developed to improve the evidence of clinical practice throughout the NHS.The HTA Programme was set up in 1993. Its role is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care.The HTA Programme commissions research only on topics where it has identified key gaps in the evidence needed by the NHS. Suggestions for topics are actively sought from people working in the NHS, the public, service-users groups and professional bodies such as Royal Colleges and NHS Trusts.Research suggestions are carefully considered by panels of independent experts (including service users) whose advice results in a ranked list of recommended research priorities. The HTA Programme then commissions the research team best suited to und...

show abstract

A controlled trial of psychological treatment for the irritable bowel syndrome

Cited by 431 publications

References 23 publications

Um marcador anatômico e a proposta de tratamento cirúrgico na síndrome do cólon irritável

Um marcador anatômico e a proposta de tratamento cirúrgico na síndrome do cólon irritável

Clinical economics review: irritable bowel syndrome

Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial

Contact Info

Product

Resources

About